Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer
Clinical trial NCT02316002 · COMPLETED
Trial details
- NCT number
- NCT02316002
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-21
- Primary completion
- 2018-09-30
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.